NEW YORK (Reuters Health) – Alpha-blockers and antibiotics relieve symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) better than other therapies, according to a network meta-analysis in the…
NEW YORK (Reuters Health) – Bladder weight estimated by ultrasound doesn’t correlate with lower urinary tract obstruction, a new study suggests. Instead, clinicians should stick with urodynamic evaluation…
NEW YORK (Reuters Health) – In boys with nonpalpable cryptorchidism, performing ultrasound before surgery to localize the testes is not necessary and shouldn’t be done, two urologists from…
NEW YORK (Reuters Health) – Brachytherapy is a viable option for prostate cancer patients 60 and younger, the authors of a new report in BJUI conclude. “Prostate cancer…
NEW YORK (Reuters Health) – Urologists from China report that the alpha-adrenergic receptor antagonist tamsulosin is a good first-line drug for outpatient medical expulsive therapy (MET) in patients…
NEW YORK (Reuters Health) – The tumor volume threshold of 0.5 mL for clinically insignificant prostate cancer, established in the early 1990s, remains valid, according to researchers who…
NEW YORK (Reuters Health) – A newer ureteral stent, designed to be more comfortable than an older stent, actually isn’t, according to results of a randomized controlled trial.…
NEW YORK (Reuters Health) – There appear to be several problems with the current clinical staging criteria for localized prostate cancer, according to a study published online today…
NEW YORK (Reuters Health) – Despite declining use, perineal radical prostatectomy (PRP) yields outcomes that are equal to, or better than, those of retropubic radical prostatectomy (RRP) and…
NEW YORK (Reuters Health) – In older men with benign prostatic hyperplasia (BPH) bothered by nocturnal polyuria, a low dose of desmopressin at bedtime can help, according to…
